Ditchcarbon
  • Customers
  1. Organizations
  2. Adagene Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 5 months ago

Adagene Inc.

Company website

Adagene Inc., a pioneering biotechnology company headquartered in China, focuses on the development of innovative antibody-based therapeutics. Founded in 2016, Adagene has rapidly established itself in the biopharmaceutical industry, particularly in the fields of immuno-oncology and precision medicine. The company is renowned for its proprietary technology platform, which enables the creation of next-generation antibodies with enhanced efficacy and safety profiles. Adagene's core products include its unique antibody drug conjugates and bispecific antibodies, setting it apart in a competitive market. With a strong presence in both domestic and international markets, Adagene has achieved significant milestones, including strategic partnerships and advancements in clinical trials, solidifying its position as a leader in antibody engineering and therapeutic development.

DitchCarbon Score

How does Adagene Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Adagene Inc.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.

14%

Let us know if this data was useful to you

Adagene Inc.'s reported carbon emissions

Adagene Inc., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Adagene may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As a result, it is unclear how Adagene Inc. aligns with broader industry efforts to combat climate change. Without emissions data or reduction initiatives, the company's climate commitments remain unspecified, highlighting a potential area for future development in sustainability practices.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Adagene Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Adagene Inc. is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Adagene Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Zai Lab

CN
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

ALX Oncology Holdings Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Shattuck Labs, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

I-Mab Biopharma

CN
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Novimmune SA

CH
•
Research and development services (73)
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy